Local therapy for the primary breast tumor in women with metastatic disease

Clinical Advances in Hematology and Oncology

Volumn 9, Issue 2, 2011, Pages 112-119

  Perez, Claudia B ^a   Khan, Seema A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Metastatic disease; Primary breast tumor

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

ARTICLE; AXILLARY SURGERY; BREAST CANCER; BREAST CONSERVING THERAPY; BREAST SURGERY; BREAST TUMOR; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE ASSOCIATION; HORMONAL THERAPY; HUMAN; LOCOREGIONAL RADIOTHERAPY; MASTECTOMY; METASTASIS POTENTIAL; OVERALL SURVIVAL; PALLIATIVE THERAPY; PARTIAL MASTECTOMY; POPULATION RESEARCH; POSTMASTECTOMY RADIATION THERAPY; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; THORAX WALL;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; NEOPLASM METASTASIS; UNITED STATES; WOMEN'S HEALTH;

EID: 80052055088     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-2106.
2. American Cancer Society. Breast Cancer Facts & Figures 2009-2010. Atlanta, GA: American Cancer Society, Inc. www2.cancer.org/downloads/STT/F861009_final%209-08-09.pdf. Accessed January 18, 2011.
3. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655-1659.
4. Andre F, Slimane K, Bachelot T, et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol. 2004;22:3302-3308.
5. Schirrmeister H, Kuhn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med. 2001;28:351-358.
6. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res. 1979;39:3861-3865.
7. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 1983;43:1488-1492.
8. Folkman J. Proceedings: tumor angiogenesis factor. Cancer Res. 1974;34:2109-2113.
9. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
10. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438:820-827.
11. Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557-563.
12. Campbell MJ, Scott J, Maecker HT, et al. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005;91:163-171.
13. Danna EA, Sinha P, Gilbert M, et al. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64:2205-2211.
14. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-626.
15. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24:2743-2749.
16. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776-782.
17. Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol. 2007;14:2187-2194.
18. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14:3345-3351.
19. Blanchard DK, Shetty PB, Hilsenbeck SG, et al. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247:732-738.
20. Cady B, Nathan NR, Michaelson JS, et al. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008;15:3384-3395.
21. Leung AM, Vu HN, Nguyen KA, Thacker LR, Bear HD. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res. 2010;161:83-88.
22. Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35:1146-1151.
23. Bafford AC, Burstein HJ, Barkley CR, et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival. Breast Cancer Res Treat. 2009;115:7-12.
24. Le Scodan R, Stevens D, Brain E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol. 2009;27:1375-1381.
25. Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G. Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat. 2010;119:537-545.
26. Neuman HB, Morrogh M, Gonen M, et al. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116:1226-1233.
27. Hazard HW, Gorla SR, Scholtens D, Kiel K, Gradishar WJ, Khan SA. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer. 2008;113:2011-2019.
28. Rao R, Feng L, Kuerer HM, et al. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol. 2008;15:1696-1702.
29. Blanchard DK, Bhatia P, Hilsenbeck SG, et al. Does surgical management of stage IV breast cancer affect outcome? Breast Cancer Res Treat. 2006;100:S118.
30. Vlastos G, Rapiti E, Bouchardy C, et al. Optimal loco-regional treatment of the primary tumor in metastatic breast cancer patients is associated with a significant survival advantage. Abstract presented at: 30th San Antonio Breast Cancer Symposium. December 13-16, 2007; San Antonio, TX. Poster 5077.
31. Dalberg K, Liedberg A, Johansson U, et al. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. Eur J Surg Oncol. 2003;29:143-154.
32. ClinicalTrials. gov. Assessing impact of loco-regional treatment on survival in metastatic breast cancer at presentation. http://clinicaltrials.gov/ct2/show/NCT00193778. Accessed January 18, 2011. ClinicalTrials.gov Identifier: NCT00193778.
33. Soran A, Ozbas S, Kelsey SF, et al. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage IV breast cancer at the presentation (protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases. Breast J. 2009;15:399-403.
34. ClinicalTrials. gov. Early surgery or standard palliative therapy in treating patients with stage IV breast cancer. clinicaltrials. gov/ct2/show/NCT01242800?t erm=ECOG+trial+E2108&rank=1. Accessed January 18, 2011. ClinicalTrials. gov Identifier: NCT01242800.